Aurobindo Pharma Ltd. has received the final approval for Cetirizine Hydrochloride Solution 1 mg/mL (OTC) from the US Food & Drug Administration (USFDA). This approval of Celirizine Hydrochloride Solution is under over-the-counter (OTC) product category.
Cetirizine Hydrochloride Solution 1 mg/mL is the generic equivalent of McNeil Consumer Healthcare Children's Zyrtec Oral Solution (Allergy), 1 mg/mL, and Childrens Zyrtec Oral Solution (Hives Relief), 1 mg/mL.
Cetrizine Hydrochloride Solution is indicated for the relief of symptoms associated with seasonal allergic rhinitis in adults and children above 2 years of age and falls under the Anti-Allergic segment. Other indications include relief from itching due to hives. The product will be launched shortly.
Aurobindo has a total of 111 ANDA approvals (83 Final approvals and 28 Tentative approvals) from USFDA.
The stock was trading at Rs.917.05, up by Rs.15.55 or 1.72%. The stock hit an intraday high of Rs.921.75 and low of Rs.890.25.
The total traded quantity was 25786 compared to 2 week average of 22346.
|
Union Budget